Heavy Metals, Label Inaccuracy, and Dose Variance
The NY Attorney General 2015 Herbal-Supplement Investigation
Evidence grade 3 of 5, Mixed. Read how the Atlas grades evidence.
The written rationale for this grade is still being prepared.
- FDA
- Quality governed by cGMP; enforcement is post-market
Reference only. Not medical advice.
What can go wrong
The risks are chronic heavy-metal exposure (especially lead and arsenic, with no safe threshold for lead), under- or over-dosing from batch variance, allergic or adverse reactions to undisclosed substitute species or fillers, and simply paying for a botanical that is not present. These harms are easy to overlook because they are silent, no dramatic effect, just contamination and inaccuracy.
This is something to take to a clinician. The Atlas can tell you what is known about heavy metals, label inaccuracy, and dose variance in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.
Even setting aside deliberate drug spiking, botanical supplements suffer from quieter quality failures: heavy-metal contamination (lead, arsenic, cadmium, mercury concentrating in plant material), inaccurate labels, and large batch-to-batch dose variance. The defining public episode was the 2015 New York Attorney General investigation, which used DNA barcoding to allege that store-brand herbal supplements from major retailers frequently contained none of the labeled botanical, or undisclosed fillers. The methodology was contested, but it crystallized the core problem: in an unregulated-for-efficacy market, the label is an unreliable guide to the contents.
What is on the label is not always what is in the bottle.
What people take it for
These are the reasons people give for taking it. They are not effects it has been shown to have.
How it is supposed to work
Quality variance in botanicals is partly intrinsic: plants concentrate soil heavy metals, and the active-compound content of an herb varies with species, growing conditions, harvest, and extraction, so two bottles of the 'same' herb can differ severalfold in potency. On top of this biological variability sit manufacturing failures: misidentified plant material, cheaper substitute species, fillers (rice, houseplants, wheat in the NY AG findings), and inadequate testing for identity and contaminants.
Why DNA barcoding both revealed and muddied the picture
The NY AG used DNA barcoding, which detects plant DNA, but many extracts are processed to the point that intact DNA is degraded, so a 'no DNA detected' result does not always mean 'no active botanical present.' Industry seized on this to dispute the findings. Yet the broader point survived the methodological fight: independent testing repeatedly finds botanicals that do not match their labels, contain contaminants, or vary wildly in dose, precisely the failure modes a pre-market system would catch.
What people get wrong
Often saidThe label reflects what is in the bottle
ActuallyIndependent testing repeatedly finds mismatches: wrong species, missing actives, fillers, and dose variance. Botanical labels are an unreliable guide to contents.
Often saidNatural means free of toxins
ActuallyPlants concentrate soil heavy metals; lead, arsenic, and cadmium contamination is a documented problem in some botanical and protein supplements.
Who profits, and who pushes back
NY Attorney General's office (2015)
Our testing found that the overwhelming majority of these herbal supplements did not contain the herbs on their labels, raising serious questions about quality and safety.
Set against the alternatives
Where the Cohen JAMA work documents deliberate drug spiking, the NY AG episode and heavy-metal data document the quieter, structural quality failures of botanicals. Both stem from the same root: no pre-market testing requirement. Third-party identity and contaminant testing (USP, NSF) directly addresses this failure mode.
What we do not know
- How prevalent is heavy-metal contamination across the botanical T-booster market?
- What is the true batch-to-batch dose variance for popular adaptogens?
- Would mandatory identity testing eliminate the substitution problem?
At a glance
- Trigger event
- NY AG investigation, February 2015
- Method used
- DNA barcoding of store-brand herbals
- Retailers named
- Walmart, Walgreens, Target, GNC
- Other quality issues
- Heavy metals, fillers, dose variance
What this entry does not yet cover
What follows is unfinished work on our side, not a finding about Heavy Metals, Label Inaccuracy, and Dose Variance. A short entry is not a safe entry.
- Timeline. We have not built the dated record of research and regulatory events.
- Cost and market. We have not documented what it sells for or who sells it.
- Supply chain. We have not mapped where it is made.
- Who uses it. We have not documented the user groups.
- What could change. No forward-looking summary yet.
- Children and teenagers. We have not checked what is known about younger people.
- Where we land. We have not taken a position on this yet.
Sources
The studies below are named and described, but not linked. You cannot open them from here and check our reading against them, which means this page is our summary of the literature rather than a document you can verify. Weigh it accordingly until the links exist.
The studies that matter
NY Attorney General herbal-supplement investigation2015
DNA barcoding allegedly found most tested store-brand herbal supplements contained none of the labeled herb or undisclosed fillers; led to cease-and-desist letters to major retailers
Newmaster et al. (DNA barcoding of herbal products)2013
Found substitution and contamination in a substantial share of tested herbal products, the academic precursor to the NY AG approach
Independent heavy-metal testing programs2010s-2020s
Repeated detection of lead, arsenic, and cadmium above safety thresholds in some botanical and protein products